Profile data is unavailable for this security.
About the company
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
- Revenue in USD (TTM)78.16m
- Net income in USD-17.57m
- Incorporated2014
- Employees674.00
- LocationBurning Rock Biotech LtdNo. 5 Xingdao Ring Road NorthInternational Bio IslandGUANGZHOU 510005ChinaCHN
- Phone+86 18 501641666
- Websitehttps://www.brbiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Joint Corp | 39.73m | 3.07m | 128.30m | 443.00 | 41.73 | 5.77 | 26.13 | 3.23 | 0.2068 | -0.067 | 2.61 | 1.50 | 0.5333 | -- | 11.04 | 89,680.70 | 4.12 | 2.29 | 7.92 | 3.38 | 78.84 | 86.62 | 7.73 | 2.67 | -- | -- | 0.00 | 0.00 | 10.47 | 1.38 | 85.73 | -- | -19.39 | -- |
| Biodesix Inc | 88.50m | -35.27m | 152.80m | 334.00 | -- | -- | -- | 1.73 | -4.73 | -4.73 | 11.71 | -0.2987 | 0.9582 | -- | 10.03 | 264,967.10 | -38.18 | -50.88 | -46.11 | -69.20 | 81.11 | 70.17 | -39.85 | -79.22 | -- | -3.60 | 1.05 | -- | 24.08 | 14.20 | 17.86 | -- | -28.63 | -- |
| Alps Group Inc | 0.00 | -2.02m | 156.92m | 2.00 | -- | -- | -- | -- | -0.5111 | -0.5111 | 0.00 | -3.06 | 0.00 | -- | -- | -- | -12.10 | -- | -23.19 | -- | -- | -- | -- | -- | -- | -7.00 | -- | -- | -- | -- | -174.11 | -- | -- | -- |
| Agilon Health Inc | 5.93bn | -405.35m | 235.40m | 856.00 | -- | 1.86 | -- | 0.0397 | -0.9782 | -0.9443 | 14.33 | 0.3056 | 3.95 | -- | 7.02 | 6,930,580.00 | -26.98 | -17.42 | -104.37 | -33.80 | -0.7641 | 4.64 | -6.83 | -6.56 | -- | -49.68 | 0.2164 | -- | -2.11 | 37.24 | -61.93 | -- | 78.94 | -- |
| Burning Rock Biotech Ltd (ADR) | 78.16m | -17.57m | 253.32m | 674.00 | -- | 3.18 | -- | 3.24 | -1.68 | -1.68 | 7.33 | 7.40 | 0.6002 | 2.41 | 2.79 | 115,964.90 | -13.50 | -37.64 | -18.61 | -45.81 | 73.02 | 69.83 | -22.48 | -124.32 | 2.91 | -- | 0.0036 | -- | -4.02 | 6.21 | 46.97 | -- | -33.43 | -- |
| Oncology Institute Inc | 461.04m | -54.66m | 265.63m | 825.00 | -- | -- | -- | 0.5762 | -0.643 | -0.643 | 5.37 | -0.1258 | 2.69 | 27.10 | 8.08 | 558,835.10 | -38.67 | -20.19 | -57.52 | -24.68 | 14.82 | 17.89 | -14.38 | -12.70 | 1.39 | -3.27 | 1.19 | -- | 21.33 | 20.41 | 21.91 | -- | 25.76 | -- |
| Viemed Healthcare Inc | 254.79m | 13.61m | 340.26m | 1.18k | 26.99 | 2.55 | 8.21 | 1.34 | 0.3316 | 0.3316 | 6.20 | 3.51 | 1.37 | 22.40 | 9.36 | 216,110.30 | 7.52 | 10.84 | 9.73 | 13.49 | 57.89 | 60.94 | 5.49 | 8.63 | 1.01 | 18.03 | 0.135 | 0.00 | 22.54 | 22.82 | 9.98 | 5.73 | 23.06 | -- |
Data as of Mar 04 2026. Currency figures normalised to Burning Rock Biotech Ltd's reporting currency: US Dollar USD
18.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kynam Capital Management LPas of 31 Dec 2025 | 994.88k | 11.01% |
| CRCM LPas of 31 Dec 2025 | 491.43k | 5.44% |
| Amova Asset Management Americas, Inc.as of 31 Dec 2025 | 31.81k | 0.35% |
| Prospera Financial Services, Inc.as of 31 Dec 2025 | 31.19k | 0.35% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 31.12k | 0.34% |
| BofA Securities, Inc.as of 31 Dec 2025 | 29.16k | 0.32% |
| Redwood Wealth Management Group LLCas of 31 Dec 2025 | 20.02k | 0.22% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 11.37k | 0.13% |
| Marshall Wace LLPas of 31 Dec 2025 | 10.90k | 0.12% |
| BNP Paribas Financial Marketsas of 31 Dec 2025 | 2.80k | 0.03% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
